Cue Biopharma Inc (CUE)
2.07
-0.11
(-5.05%)
USD |
NASDAQ |
May 08, 10:58
Cue Biopharma Market Cap: 100.69M for May 8, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 07, 2024 | 106.04M |
| May 06, 2024 | 101.18M |
| May 03, 2024 | 103.61M |
| May 02, 2024 | 91.45M |
| May 01, 2024 | 92.67M |
| April 30, 2024 | 92.42M |
| April 29, 2024 | 69.07M |
| April 26, 2024 | 66.40M |
| April 25, 2024 | 68.59M |
| April 24, 2024 | 69.07M |
| April 23, 2024 | 72.96M |
| April 22, 2024 | 76.37M |
| April 19, 2024 | 75.88M |
| April 18, 2024 | 76.86M |
| April 17, 2024 | 79.29M |
| April 16, 2024 | 72.72M |
| April 15, 2024 | 77.59M |
| April 12, 2024 | 85.13M |
| April 11, 2024 | 85.61M |
| April 10, 2024 | 86.34M |
| April 09, 2024 | 92.42M |
| April 08, 2024 | 99.23M |
| April 05, 2024 | 89.99M |
| April 04, 2024 | 86.59M |
| April 03, 2024 | 86.10M |
| Date | Value |
|---|---|
| April 02, 2024 | 88.53M |
| April 01, 2024 | 92.42M |
| March 28, 2024 | 91.94M |
| March 27, 2024 | 89.50M |
| March 26, 2024 | 89.50M |
| March 25, 2024 | 90.48M |
| March 22, 2024 | 89.71M |
| March 21, 2024 | 91.60M |
| March 20, 2024 | 93.49M |
| March 19, 2024 | 88.76M |
| March 18, 2024 | 93.96M |
| March 15, 2024 | 97.74M |
| March 14, 2024 | 95.85M |
| March 13, 2024 | 101.51M |
| March 12, 2024 | 83.57M |
| March 11, 2024 | 89.71M |
| March 08, 2024 | 93.49M |
| March 07, 2024 | 93.01M |
| March 06, 2024 | 91.60M |
| March 05, 2024 | 89.71M |
| March 04, 2024 | 95.37M |
| March 01, 2024 | 99.62M |
| February 29, 2024 | 97.97M |
| February 28, 2024 | 100.10M |
| February 27, 2024 | 111.43M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
66.40M
Minimum
Apr 26 2024
874.26M
Maximum
Jun 02 2020
274.24M
Average
187.08M
Median
Market Cap Benchmarks
| Precision BioSciences Inc | 75.25M |
| NovaBay Pharmaceuticals Inc | 2.528M |
| Palatin Technologies Inc | 33.73M |
| iBio Inc | 6.829M |
| Theriva Biologics Inc | 7.031M |
Market Cap Related Metrics
| PS Ratio | 17.25 |
| Price to Book Value | 2.715 |
| Price | 2.07 |
| Earnings Yield | -53.62% |